1. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well‐Controlled Asthma. (13th June 2017) Authors: Fowler, Andy; Koenen, Rüdiger; Hilbert, James; Blatchford, Jon; Kappeler, Dominik; Benediktus, Ewald; Wood, Chester; Gupta, Abhya Journal: Journal of clinical pharmacology Issue: Volume 57:Number 11(2017) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗